{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:23:05Z","timestamp":1791138185061,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jaci.2011.02.047","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T00:48:43Z","timestamp":1303692523000},"page":"1329-1341.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies"],"prefix":"10.1016","volume":"127","author":[{"given":"Nima","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Hedayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim E.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.02.047_bib1","series-title":"Primary immunodeficiency diseases: definition, diagnosis and management","author":"Rezaei","year":"2008"},{"key":"10.1016\/j.jaci.2011.02.047_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/07853890701436773","article-title":"DNA damage response and development of targeted cancer treatments","volume":"39","author":"Gasser","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2011.02.047_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0065-2776(05)87007-5","article-title":"The repair of DNA damages\/modifications during the maturation of the immune system: lessons from human primary immunodeficiency disorders and animal models","volume":"87","author":"Revy","year":"2005","journal-title":"Adv Immunol"},{"issue":"suppl\u00a02","key":"10.1016\/j.jaci.2011.02.047_bib5","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/onc.2009.351","article-title":"Human tumor-associated viruses and new insights into the molecular mechanisms of cancer","volume":"27","author":"Martin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2011.02.047_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcancer.2004.06.006","article-title":"Inflammation as a tumor promoter in cancer induction","volume":"14","author":"Philip","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jaci.2011.02.047_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(75)92004-8","article-title":"X-linked recessive progressive combined variable immunodeficiency (Duncan\u2019s disease)","volume":"1","author":"Purtilo","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.02.047_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2010.08442.x","article-title":"X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma","volume":"152","author":"Rezaei","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2011.02.047_bib9","series-title":"Lymphoproliferative disease, X-linked. GeneReviews","author":"Sumegi","year":"2009"},{"key":"10.1016\/j.jaci.2011.02.047_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.0105-2896.2005.00230.x","article-title":"Molecular and cellular pathogenesis of X-linked lymphoproliferative disease","volume":"203","author":"Nichols","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2011.02.047_bib11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajmg.1320400309","article-title":"Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease","volume":"40","author":"Grierson","year":"1991","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results\u00a0from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2011.02.047_bib14","doi-asserted-by":"crossref","first-page":"13765","DOI":"10.1073\/pnas.95.23.13765","article-title":"Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome","volume":"95","author":"Nichols","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.02.047_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2011.02.047_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib17","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency)","volume":"117","author":"Pachlopnik Schmid","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib18","first-page":"3118","article-title":"Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/1521-4141(200006)30:6<1691::AID-IMMU1691>3.0.CO;2-K","article-title":"Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression","volume":"30","author":"Gilmour","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/intimm\/dxf084","article-title":"Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection","volume":"14","author":"Shinozaki","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib21","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1182\/blood-2004-09-3651","article-title":"Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members","volume":"105","author":"Tabata","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.25.022106.141651","article-title":"Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules","volume":"25","author":"Ma","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0165-2478(02)00029-9","article-title":"The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells","volume":"82","author":"Nagy","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2011.02.047_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nm1189","article-title":"Regulation of NKT cell development by SAP, the protein defective in XLP","volume":"11","author":"Nichols","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0161-5890(00)00076-6","article-title":"2B4-mediated activation of human natural killer cells","volume":"37","author":"Tangye","year":"2000","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells","volume":"192","author":"Parolini","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0092-8674(82)90239-2","article-title":"Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts","volume":"30","author":"Thorley-Lawson","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2011.02.047_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.6158759","article-title":"Deficient natural killer cell activity in x-linked lymphoproliferative syndrome","volume":"210","author":"Sullivan","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.02.047_bib29","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood-2004-08-3269","article-title":"SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells","volume":"105","author":"Dupre","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib30","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/eji.200424886","article-title":"Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells","volume":"34","author":"Falco","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib31","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood-2009-09-238832","article-title":"Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets","volume":"116","author":"Hislop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib32","first-page":"2976","article-title":"Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency","volume":"119","author":"Snow","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.02.047_bib33","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.4049\/jimmunol.174.6.3153","article-title":"Signaling lymphocytic activation molecule-associated protein controls NKT cell functions","volume":"174","author":"Chung","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.20042432","article-title":"Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product","volume":"201","author":"Pasquier","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.19.1.657","article-title":"X-linked lymphoproliferative disease: a progressive immunodeficiency","volume":"19","author":"Morra","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib36","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","article-title":"Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP)","volume":"8","author":"Brandau","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib37","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood.V98.6.1986","article-title":"Manifestations of X-linked lymphoproliferative disease without prior Epstein-Barr exposure","volume":"98","author":"Schuster","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib38","doi-asserted-by":"crossref","first-page":"11966","DOI":"10.1073\/pnas.0905691106","article-title":"The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease","volume":"106","author":"Nagy","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.02.047_bib39","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1182\/blood-2007-05-092866","article-title":"Type I NKT cells protect (and type II NKT cells suppress) the host\u2019s innate antitumor immune response to a B-cell lymphoma","volume":"111","author":"Renukaradhya","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib40","doi-asserted-by":"crossref","first-page":"7935","DOI":"10.1158\/0008-5472.CAN-09-0828","article-title":"EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies","volume":"69","author":"Yuling","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2011.02.047_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/pbc.21790","article-title":"Treatment of the X-linked lymphoproliferative, Griscelli and Chediak-Higashi syndromes by HLH directed therapy","volume":"52","author":"Trottestam","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaci.2011.02.047_bib42","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood-2004-07-2965","article-title":"Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy","volume":"105","author":"Milone","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.bmt.1705016","article-title":"Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature","volume":"36","author":"Lankester","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2011.02.047_bib45","first-page":"741","article-title":"Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry","volume":"17","author":"Gross","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2011.02.047_bib46","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.02.047_bib47","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3324\/haematol.2010.033910","article-title":"IL-2-inducible T cell kinase deficiency: clinical presentation and therapeutic approach","volume":"96","author":"Stepensky","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2011.02.047_bib48","unstructured":"Borkhardt A. New forms of EBV-associated lymphoproliferation and their treatment by allo SCT. Presented at: 3rd Meeting on Clinical Immunology, Allergy and Immunodeficiencies; 2010; Tehran, Iran."},{"key":"10.1016\/j.jaci.2011.02.047_bib49","doi-asserted-by":"crossref","unstructured":"Linka RM, Huck K, Krux F, Stepensky P, Synaeve C, Vettenranta K, et\u00a0al. Germline mutations within the IL2-inducible T cell kinase impede T cell differentiation or survival, cause protein destabilisation, loss of membrane recruitment and lead to severe EBV lymphoproliferation. Presented at: American Society of Hematology Meeting; 2010; Orlando, Fla.","DOI":"10.1182\/blood.V116.21.280.280"},{"key":"10.1016\/j.jaci.2011.02.047_bib50","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.immunol.22.012703.104743","article-title":"Tec family kinases in T lymphocyte development and function","volume":"23","author":"Berg","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-2776(06)93004-1","article-title":"Tec kinases in T cell and mast cell signaling","volume":"93","author":"Felices","year":"2007","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib52","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1126\/science.284.5414.638","article-title":"Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity","volume":"284","author":"Schaeffer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaci.2011.02.047_bib53","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.192.7.987","article-title":"Tec family kinases modulate thresholds for thymocyte development and selection","volume":"192","author":"Schaeffer","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-065X.2008.00746.x","article-title":"The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development","volume":"228","author":"Prince","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2011.02.047_bib55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.2008.00757.x","article-title":"Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk\/Txk","volume":"228","author":"Readinger","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2011.02.047_bib56","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.4049\/jimmunol.168.12.6142","article-title":"The absence of Itk inhibits positive selection without changing lineage commitment","volume":"168","author":"Lucas","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib57","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2091","article-title":"Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development","volume":"7","author":"Berg","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2006.05.012","article-title":"The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells","volume":"25","author":"Atherly","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2011.02.047_bib59","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/eji.200737311","article-title":"Memory phenotype CD8+ T cells with innate function selectively develop in the absence of active Itk","volume":"37","author":"Hu","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib60","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1128\/jvi.71.10.7253-7257.1997","article-title":"Antiviral immune responses in Itk-deficient mice","volume":"71","author":"Bachmann","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2011.02.047_bib61","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.4049\/jimmunol.176.3.1571","article-title":"Tec kinases Itk and Rlk are required for CD8+ T cell responses to virus infection independent of their role in CD4+ T cell help","volume":"176","author":"Atherly","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib62","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.4049\/jimmunol.180.5.3007","article-title":"The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival","volume":"180","author":"Felices","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib63","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.4049\/jimmunol.168.5.2163","article-title":"Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase","volume":"168","author":"Miller","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib64","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.178.6.3575","article-title":"Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk","volume":"178","author":"Khurana","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.smim.2006.07.008","article-title":"Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses","volume":"18","author":"Orth","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib66","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/QCO.0b013e3282f486c9","article-title":"Epidermodysplasia verruciformis and human papilloma virus","volume":"21","author":"Gewirtzman","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaci.2011.02.047_bib67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1468-3083.2003.00703.x","article-title":"Clinical aspects of epidermodysplasia verruciformis","volume":"17","author":"de Oliveira","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2011.02.047_bib68","first-page":"169","article-title":"Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A\u00a0model for viral oncogenesis","volume":"65","author":"Lutzner","year":"1978","journal-title":"Bull Cancer"},{"key":"10.1016\/j.jaci.2011.02.047_bib69","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archderm.1985.01660070054014","article-title":"X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred","volume":"121","author":"Androphy","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib70","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1525-1470.2008.00853.x","article-title":"Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation","volume":"26","author":"McDermott","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib71","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1046\/j.1523-1747.2000.00996.x","article-title":"Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25","volume":"114","author":"Ramoz","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib72","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1044","article-title":"Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis","volume":"32","author":"Ramoz","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2164-4-24","article-title":"TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins","volume":"4","author":"Keresztes","year":"2003","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jaci.2011.02.047_bib74","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/MMBR.00033-08","article-title":"The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections","volume":"73","author":"Lazarczyk","year":"2009","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.jaci.2011.02.047_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20071311","article-title":"Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses","volume":"205","author":"Lazarczyk","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib76","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2011.02.047_bib77","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1346-8138.2003.tb00372.x","article-title":"Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis","volume":"30","author":"Pereira de Oliveira","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib78","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0190-9622(90)70058-P","article-title":"Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis","volume":"22","author":"Majewski","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib79","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/1523-1747.ep12874631","article-title":"Antigen presentation and T-cell activation in epidermodysplasia verruciformis","volume":"94","author":"Cooper","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-4632.2006.02758.x","article-title":"Current views on the role of human papillomaviruses in cutaneous oncogenesis","volume":"45","author":"Majewski","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib81","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1101\/gad.182100","article-title":"Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins","volume":"14","author":"Jackson","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaci.2011.02.047_bib82","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1038\/sj.bjc.6601829","article-title":"Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18","volume":"90","author":"Giampieri","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaci.2011.02.047_bib83","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1093\/emboj\/cdf443","article-title":"Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1","volume":"21","author":"Iftner","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2011.02.047_bib84","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.0022-202X.2004.23205.x","article-title":"High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in \u201cstripped\u201d biopsies from the same tumors","volume":"123","author":"Forslund","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib85","doi-asserted-by":"crossref","first-page":"xii","DOI":"10.1111\/j.0022-202X.2005.23811.x","article-title":"Human papillomaviruses associated with epidermodysplasia verruciformis in non-melanoma skin cancers: guilty or innocent?","volume":"125","author":"Orth","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib86","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4103\/0378-6323.69092","article-title":"Autosomal dominant epidermodysplasia verruciformis: a clinicotherapeutic experience in two cases","volume":"76","author":"Vohra","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaci.2011.02.047_bib87","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaad.2007.01.036","article-title":"Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod","volume":"56","author":"Berthelot","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib88","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-4362.2002.01642.x","article-title":"Treatment of localized epidermodysplasia verruciformis with tacalcitol ointment","volume":"41","author":"Hayashi","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib89","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1067\/mjd.2001.114575","article-title":"Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a","volume":"45","author":"Anadolu","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2011.02.047_bib90","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1067\/mjd.2003.111","article-title":"Cimetidine therapy for epidermodysplasia verruciformis","volume":"48","author":"Micali","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib91","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1046\/j.1365-2133.1999.02830.x","article-title":"Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy","volume":"140","author":"Karrer","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib92","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0105-2896.2005.00226.x","article-title":"CXCR4 mutations in WHIM syndrome: a misguided immune system?","volume":"203","author":"Diaz","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2011.02.047_bib93","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11882-005-0005-0","article-title":"WHIM syndrome: a defect in CXCR4 signaling","volume":"5","author":"Diaz","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2011.02.047_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOH.0b013e32831ac557","article-title":"WHIM syndrome: congenital immune deficiency disease","volume":"16","author":"Kawai","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaci.2011.02.047_bib95","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood-2003-10-3532","article-title":"Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome","volume":"104","author":"Gulino","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib96","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/088800100276532","article-title":"A variant of myelokathexis with hypogammaglobulinemia: lymphocytes as well as neutrophils may reverse in response to infections","volume":"17","author":"Arai","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaci.2011.02.047_bib97","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9","article-title":"WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies","volume":"91","author":"Gorlin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib99","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jaci.2011.02.047_bib100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbamem.2006.11.002","article-title":"Regulation of CXCR4 signaling","volume":"1768","author":"Busillo","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2011.02.047_bib101","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","article-title":"WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib102","first-page":"1074","article-title":"Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling","volume":"118","author":"Balabanian","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.02.047_bib103","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00277-002-0489-9","article-title":"Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome. Warts, hypogammaglobulinemia, infections, and myelokathexis","volume":"81","author":"Imashuku","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaci.2011.02.047_bib104","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mjd.2001.111337","article-title":"B-cell lymphoma in a patient with WHIM syndrome","volume":"44","author":"Chae","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2011.02.047_bib105","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jaci.2005.08.040","article-title":"Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome","volume":"116","author":"Tarzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib106","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0002-9440(10)65474-0","article-title":"Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin","volume":"155","author":"Pablos","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2011.02.047_bib107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1189\/jlb.70.2.313","article-title":"Functional HIV CXCR4 coreceptor on human epithelial Langerhans cells and infection by HIV strain X4","volume":"70","author":"Tchou","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2011.02.047_bib108","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2010-03-272096","article-title":"Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients","volume":"116","author":"Tassone","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.02.047_bib109","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3476(05)80488-3","article-title":"Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis","volume":"118","author":"Weston","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2011.02.047_bib110","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1001\/jama.1992.03480160037015","article-title":"Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF","volume":"267","author":"Wetzler","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2011.02.047_bib111","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-9343(90)90187-I","article-title":"A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia","volume":"89","author":"Wetzler","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib112","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0609.2009.01368.x","article-title":"Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome","volume":"84","author":"Krivan","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2011.02.047_bib113","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1016\/j.vaccine.2010.04.057","article-title":"A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome","volume":"28","author":"Handisurya","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2011.02.047_bib114","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.coi.2009.07.013","article-title":"Hyper-IgE syndrome","volume":"21","author":"Minegishi","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections\u2014an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib116","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","article-title":"Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity","volume":"144","author":"Renner","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2011.02.047_bib117","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2011.02.047_bib118","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1080\/10428190400004463","article-title":"Non-Hodgkin\u2019s lymphoma in Job\u2019s syndrome: a case report and literature review","volume":"45","author":"Leonard","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaci.2011.02.047_bib119","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1385\/MO:23:1:141","article-title":"Peripheral T-cell lymphoma and Job\u2019s syndrome: a rare association","volume":"23","author":"Onal","year":"2006","journal-title":"Med Oncol"},{"key":"10.1016\/j.jaci.2011.02.047_bib120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1607-551X(10)70030-9","article-title":"Hyper-IgE syndrome with Epstein-Barr virus associated extranodal NK\/T cell lymphoma of skin","volume":"26","author":"Chang","year":"2010","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jaci.2011.02.047_bib121","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1016\/j.leukres.2010.01.024","article-title":"Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy","volume":"34","author":"Belada","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2011.02.047_bib122","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib123","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","article-title":"Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome","volume":"124","author":"Engelhardt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib124","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2011.02.047_bib125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.febslet.2004.06.095","article-title":"Isolation and characterisation of DOCK8, a member of the DOCK180-related regulators of cell morphology","volume":"572","author":"Ruusala","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2011.02.047_bib126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.tcb.2007.05.001","article-title":"GEF what? Dock180 and related proteins help Rac to polarize cells in new ways","volume":"17","author":"Cote","year":"2007","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.jaci.2011.02.047_bib127","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaci.2009.05.004","article-title":"Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome","volume":"124","author":"Al Khatib","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib128","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/ni.1820","article-title":"Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production","volume":"10","author":"Randall","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib129","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00000372-200012000-00008","article-title":"Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma","volume":"22","author":"Lei","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaci.2011.02.047_bib130","first-page":"321","article-title":"Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer","volume":"28","author":"Takahashi","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jaci.2011.02.047_bib131","first-page":"501","article-title":"Novel PNLIPRP3 and DOCK8 gene expression and prognostic implications of DNA loss on chromosome 10q25.3 in hepatocellular carcinoma","volume":"10","author":"Saelee","year":"2009","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jaci.2011.02.047_bib132","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11060-008-9644-z","article-title":"Genomic changes in progression of low-grade gliomas","volume":"90","author":"Idbaih","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jaci.2011.02.047_bib133","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/ACI.0b013e32833fd718","article-title":"Dedicator of cytokinesis 8 (DOCK8) deficiency","volume":"10","author":"Su","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib134","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/bmt.2010.169","article-title":"Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation","volume":"46","author":"Gatz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2011.02.047_bib135","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/clinids\/9.2.334","article-title":"Chronic enteroviral meningoencephalitis in agammaglobulinemic patients","volume":"9","author":"McKinney","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaci.2011.02.047_bib136","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib137","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","article-title":"Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency","volume":"110","author":"Quartier","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib138","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI0215658","article-title":"Clinical and molecular analysis of patients with defects in micro heavy chain gene","volume":"110","author":"Lopez Granados","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.02.047_bib139","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00005792-198505000-00001","article-title":"X-linked agammaglobulinemia: an analysis of 96 patients","volume":"64","author":"Lederman","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2011.02.047_bib140","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0140-6736(93)90883-I","article-title":"Colorectal cancer in patients with X-linked agammaglobulinaemia","volume":"341","author":"van der Meer","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.02.047_bib141","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","article-title":"Common variable immunodeficiency: a new look at an old disease","volume":"372","author":"Park","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2011.02.047_bib142","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib143","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib144","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2011.02.047_bib145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","article-title":"Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency","volume":"25","author":"Losi","year":"2005","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib146","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"van Zelm","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib147","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib148","first-page":"136","article-title":"Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency","volume":"64","author":"Desar","year":"2006","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib149","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20050381","article-title":"Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency","volume":"202","author":"Wheat","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2011.02.047_bib150","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2249.2006.03209.x","article-title":"The T cell response to persistent herpes virus infections in common variable immunodeficiency","volume":"146","author":"Raeiszadeh","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib151","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MOH.0b013e328302c7b6","article-title":"Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics","volume":"15","author":"Chua","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaci.2011.02.047_bib152","first-page":"335","article-title":"High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia","volume":"146","author":"Liese","year":"1992","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2011.02.047_bib153","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF00918150","article-title":"Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review","volume":"12","author":"Misbah","year":"1992","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2011.02.047_bib154","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J Pediatr"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911005070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911005070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:30:25Z","timestamp":1758789025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911005070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":154,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0091674911005070"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.02.047","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14022956.15479056","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}